Table: Sapporo Clinical Lab - 6-MTH group results

Sapporo Clinical Laboratory

09/11/2018 06:30

Nov 9 (Reuters)- 
             Sapporo Clinical Laboratory Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2018        Sep 30, 2017     Mar 31, 2019 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             8.43                8.72             17.97    
                 (-3.3 pct)          (+3.4 pct)       (+2.9 pct)  
  Operating        318 mln             509 mln            1.04    
                 (-37.5 pct)         (+45.5 pct)      (+2.4 pct)  
  Recurring        330 mln             522 mln            1.06    
                 (-36.8 pct)         (+41.0 pct)      (+0.5 pct)  
  Net              206 mln             346 mln          716 mln   
                 (-40.3 pct)         (+44.7 pct)      (+4.6 pct)  
  EPS             60.05 yen           99.62 yen       207.05 yen  
  Ann Div                             11.00 yen        10.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             11.00 yen        10.00 yen  
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T